Status:

COMPLETED

The Molecular Basis for a Broad Range of Phenotypes Related to hTAS2R38

Lead Sponsor:

Monell Chemical Senses Center

Collaborating Sponsors:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Healthy

Eligibility:

All Genders

18-40 years

Brief Summary

This single-site, within-subject, experimental study is designed to test the hypothesis that individuals express taste receptors differently and have different sensitivities to bitter taste samples, w...

Eligibility Criteria

Inclusion

  • Key inclusion criteria include age 18-40 years; English speaking, and good health at the time of study participation.

Exclusion

  • Key exclusion criteria include cigarette smoking, which alters taste perception, oral disease and subjects undergoing Coumadin therapy. Subjects showing signs of oral disease, including tongue lesions or xerostomia will be excluded from tongue biopsy and therefore excluded from the study. Subjects undergoing Coumadin therapy will be excluded from tongue biopsy due to the risk of bleeding, and therefore excluded from the study. Subjects will not be excluded because of economic status, gender, race or ethnicity.

Key Trial Info

Start Date :

July 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01399944

Start Date

July 1 2011

End Date

June 1 2013

Last Update

December 18 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Monell Chemical Senses Center

Philadelphia, Pennsylvania, United States, 19104